The rule change, which HHS’ Substance Abuse and Mental Health Services Administration proposed Dec. 13, would allow clinicians to prescribe buprenorphine via telehealth visits and permit patients to receive take-home doses of methadone.
SAMSA issued a waiver allowing these flexibilities during the pandemic. Prior to these reforms, many patients had to travel to an addiction clinic daily to receive a single dose of methadone.
At present, these waivers will expire when the national public health emergency ends Jan. 11, 2023.
HHS is accepting public comments on the proposal through Feb. 14.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
